Beta Bionics, Inc. ( BBNX) - Key Metrics
BBNX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.72 | -$0.53 | -$0.33 | -$0.35 |
| 2026Q1 | $0.62 | -$0.49 | -$0.54 | -$0.57 |
| 2025Q4 | $0.79 | -$0.33 | -$0.21 | -$0.26 |
| 2025Q3 | $0.62 | -$0.33 | -$0.20 | -$0.23 |
| 2025Q2 | $0.54 | -$0.39 | -$0.31 | -$0.35 |
BBNX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -7.39 |
| 2026Q1 | 0% | -5.11 |
| 2025Q4 | 0% | -23.08 |
| 2025Q3 | 0% | -15.05 |
| 2025Q2 | 0% | -9.33 |
BBNX
Price: $19.48
52 week price:
Earnings Per Share: -1.75 USD
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 655.5 million